Severity of diabetic retinopathy is linked to lipoprotein (a) in type I diabetic patients

Diabetes and Metabolism

Volumn 25, Issue 5, 1999, Pages 412-418

  Guerci, B ^a   Meyer, L ^a   Sommer, S ^b   George, J L ^b   Ziegler, O ^a   Drouin, P ^a   Angioi Duprez K ^b  

^a Ctr Hospitalier Univ de Nancy   (France)

^b CHU NANCY BRABOIS   (France)

Author keywords

Diabetic retinopathy; Lipoprotein(a); Type 1 diabetes mellitus

Indexed keywords

LIPOPROTEIN A;

ADULT; ARTICLE; COMORBIDITY; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; RISK ASSESSMENT;

ADULT; ALBUMINURIA; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPERTENSION; LIPOPROTEIN(A); MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEINURIA; REGRESSION ANALYSIS; SMOKING; TRIGLYCERIDES;

EID: 0032726460     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
2. Barbosa J, Saner B. Do genetic factors play a role in the pathogenesis of diabetic microangiopathy? Diabetologia, 1984, 27, 487-492.
3. Kohner E.M. Porta M. Diabetic retinopathy. In: Alberti K.G.M.M. Krall L.P. eds. The diabetes annual. Amsterdam: Elsevier, 1990, 273-300.
4. Eaton DL, Fless GM, Kohr WJ, et al. Partial amino acid sequence of apolipoprotein (a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA, 1987, 84, 3224-3228.
5. Utermann G. The mysteries of lipoprotein(a). Science, 1989, 246, 904-910.
6. Seed M, Hoppichler F, Reaveley D, et al. Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart in patients with familial hypercholesterolemia. N Engl J Med, 1990, 322, 1494-1499.
7. Boerwinkle E. Genetics of plasma lipoprotein(a) concentrations. Curr Opin Lipid, 1992, 3, 128-136.
8. Kostner GM, Avogaro P, Gazzolato G, Marth E, Bittolo-Bon G, Qunici GB. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis, 1981, 38, 51-61.
9. Dahlén GH. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis, 1994, 108, 111-126.
10. Jenkins AJ, Steele JS, Janus ED, Best JD. Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes, 1991, 40, 787-790.
11. Kapelrud H, Bangstad HJ, Jorgensen KD, Berg K, Hansen KF. Serum Lp(a) lipoprotein concentrations in insulin-dependent diabetic patients with microalbuminuria. Br Med J, 1991, 303, 675-678.
12. Guillausseau PJ, Peynet J, Chanson P, et al. Lipoprotein(a) in diabetic patients with and without chronic renal failure. Diabetes Care, 1992, 15, 976-979.
13. Wollesen F, Dahlén G, Berglund L, Berne C. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes. Diabetes Care, 1999, 22, 93-98.
14. Haffner SM, Tuttle KR, Rainwater DL. Decrease of lipoprotein(a) with improved glycemic control in IDDM subjects. Diabetes Care, 1991, 14, 302-307.
15. Perez A, Carreras G, Caixas A, et al. Plasma lipoprotein(a) levels are not influenced by glycemic control in type 1 diabetes. Diabetes Care, 1998, 21, 1517-1520.
16. Maioli M, Tonolo G, Pacifico A, et al. Raised serum apolipoprotein(a) in active diabetic retinopathy. Diabetologia, 1993, 36, 88-90.
17. Ritter MM, Loscar M, Richter WO, Schwandt P. Lipoprotein(a) in diabetes mellitus. Clin Chim Acta, 1993, 214, 45-54.
18. Buscaglia P, Gazzaruso C, Garzaniti A, et al. Lipoprotein(a) and proliferate diabetic retinopathy in type II diabetes mellitus: a role for isoforms with low molecular weight. Diab Nutr Metab, 1996, 9, 129-137.
19. Kim CH, Park HJ, Park JY, Hong SK, Hoon YH, Lee KU. High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy. Diabetes Care, 1998, 21, 2149-2151.
20. Gazzaruso C, Garzaniti A, Buscaglia P, et al. Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications. Acta Diabetol, 1998, 35, 13-18.
21. Boemi M, Sirolla C, Amadio L, Fumelli P, James RW. Lipoprotein(a) and retinopathy in IDDM and NIDDM patients. Diabetes Care, 1997, 20, 115.
22. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med, 1998, 15, 539-553.
23. Massin P, Angioi-Duprez K, Bacin B, et al. Depistage, surveillance et traitement de la rétinopathie diabétique. Diabetes Metab, 1996, 22, 203-209.
24. Kohner EM, Porta M. A protocol for screening for diabetic retinopathy in Europe. Diabetic Med, 1991, 8, 263-267.
25. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia, 1995, 38, 437-444.
26. Maser RE, Usher D, Becker DJ, Drash AL, Kuller LH, Orchard TJ. Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh epidemiology of diabetes complications study cohort. Diabetes Care, 1993, 16, 755-758.
27. Haffner SM, Klein BEK, Moss SE, Klein R. Lp(a) is not related to retinopathy in diabetic subjects. Eur J Ophthalmol, 1995, 5, 119-123.
28. Westerhuis LW, Venekamp WJ. Serum lipoprotein-a levels and glycometabolic control in insulin and non-insulin-dependent diabetes mellitus. Clin Biochem, 1996, 29, 255-259.
29. Willems D, Dorchy H, Dufrasne D. Serum lipoprotein(a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications. Eur J Pediatr, 1996, 155, 175-178.
30. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy III: prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol, 1984, 102, 527-532.
31. West KM, Ahuja MMS, Bennett PH. Interrelationships of microangiopathy, plasma glucose and other risk factors in 3,583 diabetic patients: a multinational study. Diabetologia, 1982, 22, 412-420.
32. Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature, 1989, 339, 303-305.